Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effects of a Recreational Team Handball-based Programme on Health and Physical Fitness of Postmenopausal Women (H4HW)

28 de março de 2022 atualizado por: Susana Cristina Araújo Póvoas, University Institute of Maia

Effects of a Short- and Long-term Team Handball-based Exercise Programme on Physical Fitness and Health Status of Inactive Postmenopausal Women

This study aimed at determining the short- (16 weeks) and long-term (36 weeks) health and physical fitness effects and adherence of recreational team handball training for postmenopausal women without previous experience with the sport.

The investigators hypothesized that short-term recreational team handball training would result in positive health and physical fitness adaptations and that the health and physical fitness improvements achieved after the first 16 weeks would be maintained or further improved at the long-term. Moreover, the investigators also hypothesized that the adherence to this exercise mode would be maintained throughout the 36 weeks (long-term) compared to the first 16 weeks (short-term).

Visão geral do estudo

Status

Concluído

Condições

Intervenção / Tratamento

Tipo de estudo

Intervencional

Inscrição (Real)

80

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Porto
      • Maia, Porto, Portugal, 4476-690
        • University of Maia

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Fêmea

Descrição

Inclusion Criteria:

  • Inactive postmenopausal women aged +55 years or younger if with menopause for at least 3 years

Exclusion Criteria:

  • Any medical contraindications to perform moderate-to-vigorous physical activity

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Team handball group
The team handball group participants were encouraged to performed at least two out of three weekly supervised team handball training sessions of 60 min each, for 36 weeks.
Two to three weekly sessions of recreational team handball training for 36 weeks. Each 60-min session started with a standardised warm-up (including running, coordination, strength, flexibility, and balance exercises) followed by three 15-min periods of recreational team handball matches, interspersed by 2-min breaks, played as small-sided games (4v4, 5v5 or 6v6). The training sessions were performed on an indoor team handball court (40x20 m) adjusted to result in 34-36 m2 per player. During the matches, the participants rotated positions every 3 min in a random order, including the goalkeeper and no exclusions or substitutions were applied.
Sem intervenção: Control group
The control group participants were instructed to keep their regular daily physical activity for 36 weeks.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Between group differences in peak oxygen uptake at week 16
Prazo: Week 16
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 16
Between group differences in peak oxygen uptake at week 36
Prazo: Week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 36
Changes from baseline in peak oxygen uptake at week 16
Prazo: Baseline and week 16
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Baseline and week 16
Changes from baseline in peak oxygen uptake at week 36
Prazo: Baseline and week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Baseline and week 36
Changes from week 16 in peak oxygen uptake at week 36
Prazo: Week 16 and week 36
Determined by pulmonary gas exchange measurements, during an incremental treadmill test until voluntary exhaustion.
Week 16 and week 36

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Between group differences in resting heart rate at week 16
Prazo: Week 16
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 16
Between group differences in resting heart rate at week 36
Prazo: Week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 36
Changes from baseline in resting heart rate at week 16
Prazo: Baseline and week 16
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Baseline and week 16
Changes from baseline in resting heart rate at week 36
Prazo: Baseline and week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Baseline and week 36
Changes from week 16 in resting heart rate at week 36
Prazo: Week 16 and week 36
Determined by an automatic upper arm blood pressure monitor according to standardized procedures.
Week 16 and week 36
Between group differences in body mass at week 16
Prazo: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in body mass at week 36
Prazo: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in body mass at week 16
Prazo: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in body mass at week 36
Prazo: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in body mass at week 36
Prazo: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in fat mass at week 16
Prazo: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in fat mass at week 36
Prazo: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in fat mass at week 16
Prazo: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in fat mass at week 36
Prazo: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in fat mass at week 36
Prazo: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in lean mass at week 16
Prazo: Week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16
Between group differences in lean mass at week 36
Prazo: Week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 36
Changes from baseline in lean mass at week 16
Prazo: Baseline and week 16
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 16
Changes from baseline in lean mass at week 36
Prazo: Baseline and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Baseline and week 36
Changes from week 16 in lean mass at week 36
Prazo: Week 16 and week 36
Determined by whole-body dual- energy X-ray absorptiometry following standard procedures.
Week 16 and week 36
Between group differences in lumbar spine bone mineral density at week 16
Prazo: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in lumbar spine bone mineral density at week 36
Prazo: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in lumbar spine bone mineral density at week 16
Prazo: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in lumbar spine bone mineral density at week 36
Prazo: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in lumbar spine bone mineral density at week 36
Prazo: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femur bone mineral density at week 16
Prazo: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femur bone mineral density at week 36
Prazo: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femur bone mineral density at week 16
Prazo: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femur bone mineral density at week 36
Prazo: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femur bone mineral density at week 36
Prazo: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femoral neck bone mineral density at week 16
Prazo: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femoral neck bone mineral density at week 36
Prazo: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femoral neck bone mineral density at week 16
Prazo: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femoral neck bone mineral density at week 36
Prazo: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femoral neck bone mineral density at week 36
Prazo: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in lumbar spine bone mineral content at week 16
Prazo: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in lumbar spine bone mineral content at week 36
Prazo: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in lumbar spine bone mineral content at week 16
Prazo: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in lumbar spine bone mineral content at week 36
Prazo: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in lumbar spine bone mineral content at week 36
Prazo: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femur bone mineral content at week 16
Prazo: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femur bone mineral content at week 36
Prazo: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femur bone mineral content at week 16
Prazo: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femur bone mineral content at week 36
Prazo: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femur bone mineral content at week 36
Prazo: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in dominant femoral neck bone mineral content at week 16
Prazo: Week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16
Between group differences in dominant femoral neck bone mineral content at week 36
Prazo: Week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 36
Changes from baseline in dominant femoral neck bone mineral content at week 16
Prazo: Baseline and week 16
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 16
Changes from baseline in dominant femoral neck bone mineral content at week 36
Prazo: Baseline and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Baseline and week 36
Changes from week 16 in dominant femoral neck bone mineral content at week 36
Prazo: Week 16 and week 36
Determined by dual- energy X-ray absorptiometry regional scans following standard procedures.
Week 16 and week 36
Between group differences in osteocalcin at week 16
Prazo: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in osteocalcin at week 36
Prazo: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in osteocalcin at week 16
Prazo: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in osteocalcin at week 36
Prazo: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in osteocalcin at week 36
Prazo: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in procollagen type-1 amino-terminal propeptide at week 16
Prazo: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in procollagen type-1 amino-terminal propeptide at week 36
Prazo: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in procollagen type-1 amino-terminal propeptide at week 16
Prazo: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in procollagen type-1 amino-terminal propeptide at week 36
Prazo: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in procollagen type-1 amino-terminal propeptide at week 36
Prazo: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in carboxy-terminal type-1 collagen crosslinks at week 16
Prazo: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in carboxy-terminal type-1 collagen crosslinks at week 36
Prazo: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in carboxy-terminal type-1 collagen crosslinks at week 16
Prazo: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in carboxy-terminal type-1 collagen crosslinks at week 36
Prazo: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in carboxy-terminal type-1 collagen crosslinks at week 36
Prazo: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in sclerostin at week 16
Prazo: Week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16
Between group differences in sclerostin at week 36
Prazo: Week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 36
Changes from baseline in sclerostin at week 16
Prazo: Baseline and week 16
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 16
Changes from baseline in sclerostin at week 36
Prazo: Baseline and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Baseline and week 36
Changes from week 16 in sclerostin at week 36
Prazo: Week 16 and week 36
Determined by chemiluminescence method using a fully automated immunoassay system.
Week 16 and week 36
Between group differences in isometric knee extension peak torque at week 16
Prazo: Week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16
Between group differences in isometric knee extension peak torque at week 36
Prazo: Week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 36
Changes from baseline in isometric knee extension peak torque at week 16
Prazo: Baseline and week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 16
Changes from baseline in isometric knee extension peak torque at week 36
Prazo: Baseline and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 36
Changes from week 16 in isometric knee extension peak torque at week 36
Prazo: Week 16 and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16 and week 36
Between group differences in isometric knee extension rate of force development at week 16
Prazo: Week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16
Between group differences in isometric knee extension rate of force development at week 36
Prazo: Week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 36
Changes from baseline in isometric knee extension rate of force development at week 16
Prazo: Baseline and week 16
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 16
Changes from baseline in isometric knee extension rate of force development at week 36
Prazo: Baseline and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Baseline and week 36
Changes from week 16 in isometric knee extension rate of force development at week 36
Prazo: Week 16 and week 36
Determined by a Biodex isokinetic dynamometer, during a isometric knee extension contraction
Week 16 and week 36
Between group differences in upper body strength at week 16
Prazo: Week 16
Determined by a handgrip dynamometer.
Week 16
Between group differences in upper body strength at week 36
Prazo: Week 36
Determined by a handgrip dynamometer.
Week 36
Changes from baseline in upper body strength at week 16
Prazo: Baseline and week 16
Determined by a handgrip dynamometer.
Baseline and week 16
Changes from baseline in upper body strength at week 36
Prazo: Baseline and week 36
Determined by a handgrip dynamometer.
Baseline and week 36
Changes from week 16 in upper body strength at week 36
Prazo: Week 16 and week 36
Determined by a handgrip dynamometer.
Week 16 and week 36
Between group differences in postural balance at week 16
Prazo: Week 16
Determined by the number of falls in a single-legged flamingo balance test.
Week 16
Between group differences in postural balance at week 36
Prazo: Week 36
Determined by the number of falls in a single-legged flamingo balance test.
Week 36
Changes from baseline in postural balance at week 16
Prazo: Baseline and week 16
Determined by the number of falls in a single-legged flamingo balance test.
Baseline and week 16
Changes from baseline in postural balance at week 36
Prazo: Baseline and week 36
Determined by the number of falls in a single-legged flamingo balance test.
Baseline and week 36
Changes from week 16 in postural balance at week 36
Prazo: Week 16 and week 36
Determined by the number of falls in a single-legged flamingo balance test.
Week 16 and week 36
Between group differences in aerobic performance at week 16
Prazo: Week 16
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 16
Between group differences in aerobic performance at week 36
Prazo: Week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 36
Changes from baseline in aerobic performance at week 16
Prazo: Baseline and week 16
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Baseline and week 16
Changes from baseline in aerobic performance at week 36
Prazo: Baseline and week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Baseline and week 36
Changes from week 16 in aerobic performance at week 36
Prazo: Week 16 and week 36
Determined by meters covered in the Yo-Yo intermittent endurance level 1 test.
Week 16 and week 36
Between group differences in total cholesterol at week 16
Prazo: Week 16
Determined by an automated analyser.
Week 16
Between group differences in total cholesterol at week 36
Prazo: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in total cholesterol at week 16
Prazo: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in total cholesterol at week 36
Prazo: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in total cholesterol at week 36
Prazo: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in high-density lipoprotein cholesterol at week 16
Prazo: Week 16
Determined by an automated analyser.
Week 16
Between group differences in high-density lipoprotein cholesterol at week 36
Prazo: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in high-density lipoprotein cholesterol at week 16
Prazo: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in high-density lipoprotein cholesterol at week 36
Prazo: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in high-density lipoprotein cholesterol at week 36
Prazo: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in low-density lipoprotein cholesterol at week 16
Prazo: Week 16
Determined by an automated analyser.
Week 16
Between group differences in low-density lipoprotein cholesterol at week 36
Prazo: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in low-density lipoprotein cholesterol at week 16
Prazo: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in low-density lipoprotein cholesterol at week 36
Prazo: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in low-density lipoprotein cholesterol at week 36
Prazo: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in triglycerides at week 16
Prazo: Week 16
Determined by an automated analyser.
Week 16
Between group differences in triglycerides at week 36
Prazo: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in triglycerides at week 16
Prazo: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in triglycerides at week 36
Prazo: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in triglycerides at week 36
Prazo: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in fasting glucose at week 16
Prazo: Week 16
Determined by an automated analyser.
Week 16
Between group differences in fasting glucose at week 36
Prazo: Week 36
Determined by an automated analyser.
Week 36
Changes from baseline in fasting glucose at week 16
Prazo: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Changes from baseline in fasting glucose at week 36
Prazo: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Changes from week 16 in fasting glucose at week 36
Prazo: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in fasting insulin at week 16
Prazo: Week 16
Determined by an automated analyser.
Week 16
Between group differences in fasting insulin at week 36
Prazo: Week 36
Determined by an automated analyser.
Week 36
Change from baseline in fasting insulin at week 16
Prazo: Baseline and week 16
Determined by an automated analyser.
Baseline and week 16
Change from baseline in fasting insulin at week 36
Prazo: Baseline and week 36
Determined by an automated analyser.
Baseline and week 36
Change from week 16 in fasting insulin at week 36
Prazo: Week 16 and week 36
Determined by an automated analyser.
Week 16 and week 36
Between group differences in glucose tolerance at week 16
Prazo: Week 16
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 16
Between group differences in glucose tolerance at week 36
Prazo: Week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 36
Changes from baseline in glucose tolerance at week 16
Prazo: Baseline and week 16
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Baseline and week 16
Changes from baseline in glucose tolerance at week 36
Prazo: Baseline and week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Baseline and week 36
Changes from week 16 in glucose tolerance at week 36
Prazo: Week 16 and week 36
Determined by an oral glucose tolerance teste, analysed by an automated analyser.
Week 16 and week 36

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

2 de janeiro de 2016

Conclusão Primária (Real)

1 de março de 2018

Conclusão do estudo (Real)

1 de março de 2018

Datas de inscrição no estudo

Enviado pela primeira vez

14 de março de 2022

Enviado pela primeira vez que atendeu aos critérios de CQ

14 de março de 2022

Primeira postagem (Real)

23 de março de 2022

Atualizações de registro de estudo

Última Atualização Postada (Real)

6 de abril de 2022

Última atualização enviada que atendeu aos critérios de controle de qualidade

28 de março de 2022

Última verificação

1 de março de 2022

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • CEFADE202019

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever